Drug manufacturers are root cause of high drug costs; PBMs drive costs down coapharm2022-07-05T08:23:54+00:00July 5, 2022|
Democrats tweak their drug pricing plan in last-ditch effort to pass reforms coapharm2022-07-01T08:17:01+00:00July 1, 2022|
PBMs Continue to Draw Federal Scrutiny: PBM Transparency Act of 2022 coapharm2022-07-01T08:15:12+00:00July 1, 2022|
100 lawmakers ask HHS to use controversial federal laws to combat high drug prices coapharm2022-07-01T08:14:09+00:00July 1, 2022|
Viewpoints: Reforms needed to bring down Wisconsin’s 4th highest hospital prices in the country coapharm2022-07-01T08:12:41+00:00July 1, 2022|
Hospitals may have to wait to recoup 340B payments after Supreme Court ruling, attorneys say coapharm2022-07-01T08:11:30+00:00July 1, 2022|
COA Amicus Brief in 340B Contract Pharmacy Dispute COA Amicus Brief in 340B Contract Pharmacy Dispute coapharm2022-06-01T09:53:42+00:00June 1, 2022|
COA Formal Comments to FTC on Harm of Pharmacy Benefit Manager Integration COA Formal Comments to FTC on Harm of Pharmacy Benefit Manager Integration coapharm2022-05-25T13:03:35+00:00May 25, 2022|
Medicare Advantage Plans Often Deny Coverage for Eligible, Necessary Care coapharm2022-04-29T12:54:14+00:00April 29, 2022|